Federal contract award
75F40121C00137
AREA OF NEED: DRUG DEVELOPMENT FOR PEDIATRIC CANCERS HAS HISTORICALLY LAGGED FAR BEHIND ADULT CANCERS, AND MOSTLY RELIED ON A ?TRICKLE DOWN? EFFECT FROM ADULT ONCOLOGY. FURTHERMORE, THERE IS OFTEN A GAP OF 5-10 YEARS BETWEEN ADULT AND PEDIATRIC APP
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.0M |
| Current contract value | $1.0M |
| Potential contract value / ceiling | $1.0M |
| Start date | Sep 8, 2021 |
| Current end date | Sep 7, 2026 |
| Potential end date | Sep 7, 2026 |
| Latest award activity | May 24, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 24, 2024 | P00004 | $0 | NO-COST MODIFICATION TO EXTEND THE PERIOD OF PERFORMANCE END DATE TO 09/07/2026. |
| Jun 15, 2023 | P00003 | $0 | OC/OCE REQUEST TO RE-BUDGET FUNDS WITHIN THE CONTRACT FOR CONTRACT 75F40121C00137 |
| Feb 15, 2023 | P00002 | $0 | OC/OCE REQUEST TO RE-BUDGET FUNDS WITHIN THE CONTRACT FOR CONTRACT 75F40121C00137 |
| Mar 24, 2022 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE HHSAR 352.232-71, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (FEB 2022) AND FDA ELECTRONIC INVOICING AND PAYMENT REQUIREMENTS - INVOICE PROCESSING PLATFORM (IPP) (JAN 2022). |
| Sep 8, 2021 | 0 | $1.0M | AREA OF NEED: DRUG DEVELOPMENT FOR PEDIATRIC CANCERS HAS HISTORICALLY LAGGED FAR BEHIND ADULT CANCERS, AND MOSTLY RELIED ON A ?TRICKLE DOWN? EFFECT FROM ADULT ONCOLOGY. FURTHERMORE, THERE IS OFTEN A GAP OF 5-10 YEARS BETWEEN ADULT AND PEDIATRIC APP |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Robert Maydwell | Contact | Robert.Maydwell@fda.hhs.gov 301-348-1814 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | Jan 28, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Jan 28, 2021 |
| Benjamin Golway | Contact | Benjamin.Golway@fda.hhs.gov 3018374464 | Source | Nov 20, 2020 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Nov 20, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.